Deutsche Bank’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-541
| Closed | -$1.1K | – | 3570 |
|
|
2025
Q1 | $1.1K | Buy |
+541
| New | +$1.1K | ﹤0.01% | 3514 |
|
|
2023
Q3 | – | Sell |
-4,062
| Closed | -$52.6K | – | 3623 |
|
|
2023
Q2 | $52.6K | Sell |
4,062
-1,307
| -24% | -$16.9K | ﹤0.01% | 3454 |
|
|
2023
Q1 | $68.1K | Buy |
+5,369
| New | +$68.1K | ﹤0.01% | 3452 |
|